Evidence map›Paper›PMID 39078440›Full record

ArticleMedical molecular morphology2024

Clinical and pathological analyses of 14 cases of angiomatoid fibrous histiocytoma.

Qiang Zeng, Jie-Zhen Li, Guo-Ping Li, Yu-Peng Chen, Fang-Ling Song, Feng Gao

Abstract read
PubMed Publisher
In one paragraph

Article in Medical molecular morphology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Angiomatoid fibrous histiocytoma: a review.Journal of pathology and translational medicine · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qiang ZengDepartment of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350004, China.
Jie-Zhen LiDepartment of Pathology, Fujian Provincial Hospital, Fuzhou, 350001, China. lijiezhen12345@163.com.
Guo-Ping LiDepartment of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350004, China.
Yu-Peng ChenDepartment of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350004, China.
Fang-Ling SongDepartment of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350004, China.
Feng GaoDepartment of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350004, China.

Funding

National Key Clinical Specialty Discipline Construction Program of China 2022YBL-ZD-02
6 · The paper itself

Abstract

Angiomatoid fibrous histiocytoma (AFH) is a soft tissue tumor of uncertain differentiation. Although its prognosis is good, its diagnosis and differential diagnosis remain a challenge, particularly for tumors with an atypical morphology. We evaluated the clinicopathological characteristics of 14 AFH cases and examined the key factors in its diagnosis or differential diagnosis. The cohort comprised 6 men and 8 women aged 9-65 years (average age: 31.2 years). Most of the tumors (11/14, 79%) were located in soft tissues, whereas 3/14 (21%) were located in the lung (1 case) and brain (2 cases). Tumor cells were spindle-shaped to epithelioid, with a visible fibrous capsule (9/14, 64%), hemorrhagic gap (9/14, 64%), lymphocyte sleeve (7/14, 50%), necrosis (3/14, 21%), and infiltrative boundary (4/14, 29%). The tumors expressed desmin (10/14, 71%) and exhibited low levels of Ki-67. 13 cases (93%) displayed ESWSR1 gene rearrangement. At follow-up, 1 case (7%) experienced local tumor recurrence. AFH is a rare intermediate tumor. Its pathological diagnosis requires a comprehensive analysis of histological, immunophenotypic, and molecular genetic features to avoid misdiagnosis. Our study has further enriched the histological features of AFH, emphasizing the importance of differential diagnosis and providing a reference for clinical practice.

Indexed as

Histiocytoma, Malignant FibrousAdolescentAdultAgedBiomarkers, TumorChildDesminDiagnosis, DifferentialFemaleGene RearrangementHumansKi-67 AntigenMaleMiddle AgedRNA-Binding Protein EWSSoft Tissue NeoplasmsBiomarkers, TumorDesminEWSR1 protein, humanKi-67 AntigenRNA-Binding Protein EWSAngiomatoid fibrous histiocytomaClinicopathological characteristicsEWSR1 mutationSoft tissue tumors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.